Patents by Inventor Mickey L. WELLS

Mickey L. WELLS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations of oxabicycloheptanes and oxabicycloheptenes
    Patent number: 11931354
    Abstract: The invention relates to a pharmaceutical composition comprising a protein phosphatase 2A (PP2A) inhibitor and monosodium glutamate.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: March 19, 2024
    Assignee: Lixte Biotechnology, Inc.
    Inventors: John S. Kovach, Mickey L. Wells
  • METHODS FOR TREATING SOFT TISSUE SARCOMA
    Publication number: 20240041864
    Abstract: The invention relates to a pharmaceutical composition comprising a protein phosphatase 2A (PP2A) inhibitor and monosodium glutamate.
    Type: Application
    Filed: June 16, 2023
    Publication date: February 8, 2024
    Inventors: John S. KOVACH, Mickey L. WELLS
  • FORMULATIONS OF OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES
    Publication number: 20200179375
    Abstract: The invention relates to a pharmaceutical composition comprising a protein phosphatase 2A (PP2A) inhibitor and monosodium glutamate.
    Type: Application
    Filed: December 6, 2019
    Publication date: June 11, 2020
    Inventors: John S. Kovach, Mickey L. Wells
  • Formulations of oxabicycloheptanes and oxabicycloheptenes
    Patent number: 10532050
    Abstract: The invention relates to a pharmaceutical composition comprising a protein phosphatase 2A (PP2A) inhibitor and monosodium glutamate.
    Type: Grant
    Filed: April 8, 2014
    Date of Patent: January 14, 2020
    Assignee: Lixte Biotechnology, Inc.
    Inventors: John S. Kovach, Mickey L. Wells
  • FORMULATIONS OF OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES
    Publication number: 20160051544
    Abstract: The invention relates to a pharmaceutical composition comprising a protein phosphatase 2A (PP2A) inhibitor and monosodium glutamate.
    Type: Application
    Filed: April 8, 2014
    Publication date: February 25, 2016
    Applicant: Lixte Biotechnology, Inc.
    Inventors: John S. KOVACH, Mickey L. WELLS